6.5.2024
2.5.2024
7
May
2024
8
Find more news and events
Suomeksi
In English
The Proof of Concept ideas funded in 2021 included a functional biomarker for Alzheimer's disease, a mathematic algorithm for the personalized prediction of aortic rupture, and enzymes cleaving biomass fibers.
The coronavirus pandemic has increased general interest in how viruses enter the brain, and what their effects on the brain are. There are receptors on the surface of some brain cells which allow the coronavirus to penetrate the cell.
The University of Eastern Finland has received EU funding to recruit 14 doctoral students into a four-year multidisciplinary Neuro-Innovation PhD programme, which will be implemented on the Kuopio campus.
The aim of the new national competence network is to increase cooperation between universities, hospitals, and the business worlds and to make Finnish neuroscience know-how visible internationally.
In the doctoral thesis of Meike H. Keuters, MSc, three promising compounds have been shown to improve the post-stroke outcome in mouse models of ischemic stroke.
Rokote Laboratories Finland Ltd., is a newly-founded, Finnish academic spin-out working to develop and introduce to the markets a nasal spray vaccine against COVID.
Research and clinical work with patients generate so much imaging data that their efficient use is impossible without image analysis methods that are based on artificial intelligence. A new image analysis centre to be set up in Kuopio will provide support for patient care as well as for companies and research groups whose work involves imaging.
According to a new study published in The American Journal of Human Genetics, more than one third of genetic variants that increase the risk of coronary artery disease regulate the expression of genes in the liver.
Certain plasma microRNAs could serve as diagnostic biomarkers in mild traumatic brain injury, a new study from the University of Eastern Finland shows.
Sigrid Jusélius Foundation has granted a senior researcher post to Docent Šárka Lehtonen. Her lab develops human-based models to study the mechanisms of Parkinson’s disease.